Skip to content

Testing an Optimal Model of Patient-Centered Cancer Care

Testing an Optimal Model of Patient-Centered Cancer Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00921713
Enrollment
300
Registered
2009-06-16
Start date
2008-09-30
Completion date
2013-08-31
Last updated
2017-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Early cancer care

Brief summary

The purpose of this proposal is to develop and test the efficacy in a randomized, controlled clinical trial of an Oncology Nurse Care Management (ONCM) program to support cancer patients early in their course. The ONCM program will be compared with an Enhanced Usual Care (EUC) program that will provide education materials and treatment resources for patients. Efficacy will be measured by differences over time in participant-reported Quality of Life, Symptoms and Emotional Distress, and Quality of Care between patients receiving ONCM versus EUC.

Detailed description

Overall Goal: Our primary goal is to assess the impact on quality of life, quality of care, and other outcomes of two programs designed to support patients newly diagnosed with breast, colorectal, and lung cancer patients. The Oncology Nurse Care Management (ONCM) and Enhanced Usual Care (EUC) interventions will be implemented and evaluated among enrollees of Group Health. Specific Aims: A.1. To develop a robust early cancer notification system based on automated data to facilitate intervention shortly after cancer diagnosis. A.2. To implement an Oncology Nurse Care Management program that addresses patient questions, symptoms, psychosocial needs, and facilitates timely, coordinated care. A.3. To compare the impact of the Oncology Nurse Care Manager Program with Enhanced Usual Care in Group Health cancer patients using a randomized clinical trial design. Our two primary outcomes are quality of life and patients' perspectives of quality of care. As secondary outcomes, we will evaluate the impact of the intervention on psychosocial distress and depression.

Interventions

OTHEROncology Nurse Care Management
OTHERPatient-centered materials

Sponsors

Kaiser Permanente
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. On the panel of an eligible and consenting primary care physician; 2. Diagnosed with a new occurrence of breast (females only) , colorectal, or lung cancer within the past three weeks; 3. Age 18 or older; and 4. Able to complete the baseline questionnaire.

Exclusion criteria

1. They plan to disenroll from GH or be out of the area in the coming year; or 2. Primary care physician or specialty physician expects survival to be less than 12 months; or 3. Don't speak English; or 4. Have moderate cognitive impairment (a score of 3 or more on a six-item validated instrument, or psychosis as assessed by ICD-9 codes from GH medical record data.

Design outcomes

Primary

MeasureTime frame
Quality of life and satisfaction with care between patients in Oncology Nurse Care Management versus Enhanced Usual Care5/2009 - 8/2011

Secondary

MeasureTime frame
Treatment adherence and treatment outcomes of patients in Oncology Nurse Care Management versus Enhanced Usual Care5/2009 - 8/2011

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026